We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current LYRA market cap is 221.82M. The company's latest EPS is USD -1.1925 and P/E is -3.37.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | -4.42M | 11k | 410k | 458k | 544k |
| Operating Income | -19.61M | -15.16M | -17.31M | -14.91M | -16.83M |
| Net Income | -19.55M | -14.24M | -16.26M | -15.62M | -15.65M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 285k | 1.36M | 1.56M |
| Operating Income | -16.52M | -22.21M | -43.62M | -56.31M | -67.12M |
| Net Income | -16.31M | -22.13M | -43.51M | -55.28M | -62.68M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 119.46M | 109.97M | 93.87M | 125.68M | 120.58M |
| Total Liabilities | 26.24M | 29.21M | 27.78M | 27.1M | 36.34M |
| Total Equity | 93.22M | 80.75M | 66.09M | 98.58M | 84.24M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 14.96M | 80.83M | 54.87M | 109.97M | 142.6M |
| Total Liabilities | 7.64M | 6.34M | 20.55M | 29.21M | 53.18M |
| Total Equity | -123.34M | 74.49M | 34.32M | 80.75M | 89.42M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -31.22M | -43.39M | -15.85M | -30.13M | -44.25M |
| Investing | -136k | -65.01M | 5.32M | 4.75M | -10.23M |
| Financing | 96.26M | 96.26M | 4k | 47.19M | 46.77M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.75M | -21.14M | -25.82M | -43.39M | -63.3M |
| Investing | -211k | -1.78M | -3.39M | -65.01M | -12.58M |
| Financing | -115k | 87.7M | 359k | 96.26M | 65.69M |
| Market Cap | 221.82M |
| Price to Earnings Ratio | -3.37 |
| Price to Sales Ratio | 135.81 |
| Price to Cash Ratio | 9.45 |
| Price to Book Ratio | 2.36 |
| Dividend Yield | - |
| Shares Outstanding | 52.56M |
| Average Volume (1 week) | 353.97k |
| Average Volume (1 Month) | 280.47k |
| 52 Week Change | 54.01% |
| 52 Week High | 6.79 |
| 52 Week Low | 2.36 |
| Spread (Intraday) | 0.27 (6.24%) |
| Company Name | Lyra Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://lyratherapeutics.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
